Cargando…
Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage
BACKGROUND: A global programme to eliminate lymphatic filariasis (GPELF) is underway, yet two key programmatic features are currently still lacking: (1) the extension of efforts to all lymphatic filariasis (LF) endemic countries, and (2) the expansion of geographic coverage of mass drug administrati...
Autores principales: | Stone, Christopher M, Kastner, Randee, Steinmann, Peter, Chitnis, Nakul, Tanner, Marcel, Tediosi, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321305/ https://www.ncbi.nlm.nih.gov/pubmed/28588916 http://dx.doi.org/10.1136/bmjgh-2015-000021 |
Ejemplares similares
-
What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs
por: Kastner, Randee J., et al.
Publicado: (2015) -
How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis
por: Kastner, Randee J., et al.
Publicado: (2017) -
Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges
por: Tediosi, Fabrizio, et al.
Publicado: (2013) -
How Effective is Integrated Vector Management Against Malaria and Lymphatic Filariasis Where the Diseases Are Transmitted by the Same Vector?
por: Stone, Christopher M., et al.
Publicado: (2014) -
The geographical distribution of lymphatic filariasis infection in Malawi
por: Ngwira, Bagrey MM, et al.
Publicado: (2007)